| 
                      
                        | 
                            
                              | HOUSE AMENDMENT |  
                              | Bill No. CS/SB 8E |  |  | 
                
                  |  |  | 
                1 | CHAMBER ACTION | 
                | 2 |  | 
              
                | 3 | . | 
              
                | 4 | . | 
              
                | 5 | . | 
              
                | 6 |  | 
              
                | 7 |  | 
              
                | 8 |  | 
              
                | 9 |  | 
              
                | 10 |  | 
              
                | 11 |  | 
              
                | 12 | Representative Seiler offered the following: | 
              
                | 13 |  | 
              
                | 14 | Amendment (with title amendment) | 
              
                | 15 | On page 1, line 28, | 
              
                | 16 | remove:  everything after the enacting clause, | 
              
                | 17 |  | 
              
                | 18 | and insert: | 
              
                | 19 | Section 1.  Section 288.145, Florida Statutes, is created | 
              
                | 20 | to read: | 
              
                | 21 | 288.145  Scripps Florida Funding Corporation and Scripps | 
              
                | 22 | Florida; public records exemption; public meetings exemption.-- | 
              
                | 23 | (1)  The following information held by Scripps Florida, a | 
              
                | 24 | not-for-profit entity, or a division, subsidiary, affiliate, or | 
              
                | 25 | entity formed by The Scripps Research Institute to establish a | 
              
                | 26 | state-of-the-art biomedical research campus in the state, | 
              
                | 27 | hereinafter referred to as the "grantee," as defined in s. | 
              
                | 28 | 288.955, or received from the grantee and held by the Scripps | 
              
                | 29 | Florida Funding Corporation as created by s. 288.955, is | 
              
                | 30 | confidential and exempt from the provisions of s. 119.07(1) and | 
              
                | 31 | s. 24(a), Art. I of the State Constitution: | 
              
                | 32 | (a)  Materials that relate to methods of manufacture or | 
              
                | 33 | production unique to the grantee or Scripps Florida Funding | 
              
                | 34 | Corporation, potential trade secrets such as patentable material | 
              
                | 35 | for which a patent is pending, patentable material, actual trade | 
              
                | 36 | secrets as defined in s. 688.002, or proprietary information | 
              
                | 37 | which is patented or patentable or trademarked or capable of | 
              
                | 38 | being trademarked or which constitutes a trade secret, received, | 
              
                | 39 | generated, ascertained, or discovered during the course of | 
              
                | 40 | research conducted by or through the grantee, and business | 
              
                | 41 | transactions resulting from such research that could result in | 
              
                | 42 | an unfair competitive advantage to others. | 
              
                | 43 | (b)  Any information received from a person from another | 
              
                | 44 | state or nation or the Federal Government which is otherwise | 
              
                | 45 | exempt or confidential pursuant to the laws of that state or | 
              
                | 46 | nation or pursuant to federal law. | 
              
                | 47 | (2)  Any information received by the grantee or Scripps | 
              
                | 48 | Florida Funding Corporation in the performance of its duties and | 
              
                | 49 | responsibilities which is otherwise confidential and exempt by | 
              
                | 50 | law is confidential and exempt from the provisions of s. | 
              
                | 51 | 119.07(1) and s. 24(a), Art. I of the State Constitution. | 
              
                | 52 | (3)  The following information held by the grantee is | 
              
                | 53 | confidential and exempt from the provisions of s. 119.07(1) and | 
              
                | 54 | s. 24(a), Art. I of the State Constitution: | 
              
                | 55 | (a)  Personal identifying information relating to | 
              
                | 56 | individuals who participate in human trials or experiments of | 
              
                | 57 | programs created or funded through the grantee. | 
              
                | 58 | (b)  Any medical or health records relating to patients. | 
              
                | 59 | (4)  That portion of a meeting of the Scripps Florida | 
              
                | 60 | Funding Corporation at which information is presented or | 
              
                | 61 | discussed that is confidential and exempt pursuant to | 
              
                | 62 | subsections (1) and (2) is exempt from the provisions of s. | 
              
                | 63 | 286.011 and s. 24(b), Art. I of the State Constitution. | 
              
                | 64 | (5)  The Auditor General, the Office of Program Policy | 
              
                | 65 | Analysis and Government Accountability, and the Office of | 
              
                | 66 | Tourism, Trade, and Economic Development, pursuant to their | 
              
                | 67 | oversight and auditing functions, shall be given access to all | 
              
                | 68 | information made confidential and exempt pursuant to subsections | 
              
                | 69 | (1), (2), and (3), upon request and without subpoena, and shall | 
              
                | 70 | maintain the confidential and exempt status of the information | 
              
                | 71 | so received. | 
              
                | 72 | (6)  Any audit or oversight report generated pursuant to | 
              
                | 73 | subsection (5), when final, shall be a public record. The audit | 
              
                | 74 | and oversight workpapers and notes are confidential and exempt | 
              
                | 75 | from the provisions of s. 119.07(1) and s. 24(a), Art. I of the | 
              
                | 76 | State Constitution; however, those workpapers necessary to | 
              
                | 77 | support the computations in the final audit report may be made | 
              
                | 78 | available by a majority vote of the Legislative Auditing | 
              
                | 79 | Committee after a public hearing showing proper cause. The audit | 
              
                | 80 | or oversight workpapers and notes shall be retained by the | 
              
                | 81 | entity generating the report until no longer useful, after which | 
              
                | 82 | time the workpapers and notes may be destroyed. | 
              
                | 83 | Section 2.  Section 288.145, Florida Statutes, is subject | 
              
                | 84 | to the Open Government Sunset Review Act of 1995 in accordance | 
              
                | 85 | with s. 119.15, Florida Statutes, and shall stand repealed on | 
              
                | 86 | October 2, 2009, unless reviewed and saved from repeal through | 
              
                | 87 | reenactment by the Legislature. | 
              
                | 88 | Section 3.  The Legislature finds that it is a public | 
              
                | 89 | necessity that certain information held by Scripps Florida, a | 
              
                | 90 | not-for-profit entity, or a division, subsidiary, affiliate, or | 
              
                | 91 | entity formed by The Scripps Research Institute to establish a | 
              
                | 92 | state-of-the-art biomedical research campus in the state, | 
              
                | 93 | hereinafter referred to as the "grantee," as defined in s. | 
              
                | 94 | 288.955, Florida Statutes, or received from the grantee and held | 
              
                | 95 | by the Scripps Florida Funding Corporation as created in s. | 
              
                | 96 | 288.955, Florida Statutes, which information is proprietary | 
              
                | 97 | confidential business information, be held confidential and | 
              
                | 98 | exempt from public records requirements. Materials and | 
              
                | 99 | information held by the grantee or obtained from the grantee and | 
              
                | 100 | held by the corporation concerning methods of manufacture or | 
              
                | 101 | production unique to the grantee or Scripps Florida Funding | 
              
                | 102 | Corporation, actual trade secrets, potential trade secrets such | 
              
                | 103 | as patentable material for which a patent is pending, patentable | 
              
                | 104 | materials, or proprietary information which is patented or | 
              
                | 105 | patentable or trademarked or capable of being trademarked or | 
              
                | 106 | which constitutes a trade secret, received, generated, | 
              
                | 107 | ascertained, or discovered during the course of research | 
              
                | 108 | conducted by or through the grantee, and business transactions | 
              
                | 109 | resulting from such research that could result in an unfair | 
              
                | 110 | competitive advantage to others must be held confidential and | 
              
                | 111 | exempt from public records requirements because the disclosure | 
              
                | 112 | of such information would create an unfair competitive advantage | 
              
                | 113 | for the person receiving such information. Such an advantage | 
              
                | 114 | would adversely impact the grantee. If confidential and exempt | 
              
                | 115 | information regarding research in progress were released | 
              
                | 116 | pursuant to a public records request, others would be allowed to | 
              
                | 117 | derive benefit from the research without compensation or | 
              
                | 118 | reimbursement to the grantee. The Legislature further finds that | 
              
                | 119 | information obtained by the grantee or the corporation from a | 
              
                | 120 | person in another state or nation or the Federal Government | 
              
                | 121 | which is otherwise exempt or confidential pursuant to the laws | 
              
                | 122 | of that state or nation or pursuant to federal law should remain | 
              
                | 123 | exempt or confidential because the highly confidential nature of | 
              
                | 124 | research necessitates that the grantee or corporation be | 
              
                | 125 | authorized to maintain the status of such information it | 
              
                | 126 | receives. Without the exemptions provided for in this act, the | 
              
                | 127 | disclosure of confidential and exempt information would place | 
              
                | 128 | the grantee on an unequal footing in the marketplace as compared | 
              
                | 129 | with other research competitors whose information is kept | 
              
                | 130 | confidential and exempt. The Legislature finds that disclosure | 
              
                | 131 | of confidential and exempt information would adversely impact | 
              
                | 132 | the grantee's fulfilling the mission of research. It is further | 
              
                | 133 | a public necessity that the grantee and the corporation have the | 
              
                | 134 | same confidential protections for other information received in | 
              
                | 135 | the performance of their duties and responsibilities, which is | 
              
                | 136 | otherwise confidential and exempt by law, in order to put the | 
              
                | 137 | grantee on an equal footing with other public research | 
              
                | 138 | institutes and to ensure that the grantee has similar | 
              
                | 139 | opportunities for success as its other research competitors. The | 
              
                | 140 | Legislature further finds that it is a public necessity that | 
              
                | 141 | personal, medical, or health information held by the grantee | 
              
                | 142 | concerning individuals who participate in human trials or | 
              
                | 143 | experiments of programs created or funded through the grantee or | 
              
                | 144 | patients of the grantee be made confidential and exempt from | 
              
                | 145 | public disclosure because access to such information would be an | 
              
                | 146 | unwarranted invasion of the individual’s or patient’s right to | 
              
                | 147 | privacy. Also, misuse of such sensitive personal, medical, or | 
              
                | 148 | health information could be detrimental to the health, safety, | 
              
                | 149 | or welfare of the individual or patient. The Legislature further | 
              
                | 150 | finds that it is a public necessity that portions of meetings of | 
              
                | 151 | the corporation at which confidential and exempt information is | 
              
                | 152 | presented or discussed be exempt from public meetings | 
              
                | 153 | requirements in order to allow the corporation to maintain the | 
              
                | 154 | confidential and exempt status of that information and to | 
              
                | 155 | prevent an unfair competitive advantage for the persons | 
              
                | 156 | receiving this information. Moreover, disclosing information | 
              
                | 157 | made confidential and exempt pursuant to the corporation’s | 
              
                | 158 | public records exemption via an open meeting defeats the purpose | 
              
                | 159 | of the public records exemption. The Legislature also finds that | 
              
                | 160 | it is a public necessity that information obtained from the | 
              
                | 161 | grantee and the corporation and held by the Auditor General, the | 
              
                | 162 | Office of Program Policy Analysis and Government Accountability, | 
              
                | 163 | and the Office of Tourism, Trade, and Economic Development be | 
              
                | 164 | confidential and exempt from public disclosure because of the | 
              
                | 165 | highly confidential nature of research. Release of such | 
              
                | 166 | information would place the grantee on an unequal footing in the | 
              
                | 167 | marketplace as compared with other private research competitors | 
              
                | 168 | whose information is kept confidential and exempt. Finally, the | 
              
                | 169 | Legislature finds that it is a public necessity that audit or | 
              
                | 170 | oversight workpapers and notes obtained by the grantee and held | 
              
                | 171 | by the Auditor General, the Office of Program Policy Analysis | 
              
                | 172 | and Government Accountability, and the Office of Tourism, Trade, | 
              
                | 173 | and Economic Development be confidential and exempt from public | 
              
                | 174 | disclosure because such workpapers and notes are incomplete and | 
              
                | 175 | could be misleading. Release of inaccurate or incomplete | 
              
                | 176 | information could be detrimental to the grantee or the Scripps | 
              
                | 177 | Florida Funding Corporation. | 
              
                | 178 | Section 4.  This act shall take effect upon becoming a law | 
              
                | 179 | if HB 1-E or similar legislation is adopted in the same | 
              
                | 180 | legislative session or an extension thereof and becomes law. | 
              
                | 181 |  | 
              
                | 182 | ================= T I T L E  A M E N D M E N T ================= | 
              
                | 183 | On page 1, lines 2 through 25, | 
              
                | 184 | remove:  all of said lines, | 
              
                | 185 |  | 
              
                | 186 | and insert: | 
              
                | 187 | An act relating to public records and public meetings | 
              
                | 188 | exemptions; creating s. 288.145, F.S.; creating an | 
              
                | 189 | exemption from public records requirements for specified | 
              
                | 190 | materials, actual and potential trade secrets, patentable | 
              
                | 191 | material, specified proprietary information received, | 
              
                | 192 | generated, ascertained, or discovered during the course | 
              
                | 193 | of research conducted by or through Scripps Florida, a | 
              
                | 194 | not-for-profit entity, or a division, subsidiary, | 
              
                | 195 | affiliate, or entity formed by The Scripps Research | 
              
                | 196 | Institute to establish a state-of-the-art biomedical | 
              
                | 197 | research campus in the state, hereinafter referred to as | 
              
                | 198 | the "grantee," specified business transactions resulting | 
              
                | 199 | from such research, and information received from a | 
              
                | 200 | person from another state or nation or the Federal | 
              
                | 201 | Government which is otherwise exempt or confidential, | 
              
                | 202 | held by the grantee or received from the grantee and held | 
              
                | 203 | by the Scripps Florida Funding Corporation; creating an | 
              
                | 204 | exemption from public records requirements for | 
              
                | 205 | information received by the grantee or Scripps Florida | 
              
                | 206 | Funding Corporation in the performance of its duties and | 
              
                | 207 | responsibilities and which is otherwise confidential and | 
              
                | 208 | exempt; creating an exemption from public records | 
              
                | 209 | requirements for personal identifying information held by | 
              
                | 210 | the grantee relating to individuals who participate in | 
              
                | 211 | human trials or experiments of programs created or funded | 
              
                | 212 | through the grantee and medical or health records | 
              
                | 213 | relating to patients; creating an exemption from public | 
              
                | 214 | meetings requirements for portions of meetings of the | 
              
                | 215 | Scripps Florida Funding Corporation at which confidential | 
              
                | 216 | and exempt information is presented or discussed; | 
              
                | 217 | providing for access to confidential and exempt | 
              
                | 218 | information by specified agencies; providing that | 
              
                | 219 | specified audits or oversight reports are public records | 
              
                | 220 | when final; creating a public records exemption for audit | 
              
                | 221 | and oversight workpapers and notes; providing for | 
              
                | 222 | retention of workpapers and notes for a specified period; | 
              
                | 223 | providing for future review and repeal; providing a | 
              
                | 224 | statement of public necessity; providing a contingent | 
              
                | 225 | effective date. |